{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-127595","form_type":"8-K","ticker":"ANTX","cik":"0001880438","company_name":"AN2 Therapeutics, Inc.","filed_at":"2025-05-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.357549+00:00","generated_at":"2026-05-20T11:29:21.367811+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"AN2 Therapeutics stockholders elect three Class III directors and ratify PwC as auditor","bullets":["Eric Easom, Stephanie Wong, and Joseph Zakrzewski elected as Class III directors for term expiring 2028.","Easom received 13,983,213 votes for; Wong 10,584,641; Zakrzewski 10,928,200; each had 3,403,334 broker non-votes.","Ratification of PricewaterhouseCoopers LLP as independent auditor passed with 23,736,942 votes for, 47,413 against, 144,085 abstentions.","Approximately 79.50% of outstanding shares (23,928,440) represented at the meeting, constituting a quorum."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-127595","json":"https://secwatch.observer/filing/0001193125-25-127595.json","markdown":"https://secwatch.observer/filing/0001193125-25-127595.md","text":"https://secwatch.observer/filing/0001193125-25-127595.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1880438/000119312525127595/0001193125-25-127595-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1880438/000119312525127595/d82533d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T11:29:21.367811+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}